Episode 295: PREMIUM – Taking a run at the SPRINT trial
In episode 295, Mike and James discuss the latest blood pressure target trial in an impressive PREMIUM way. We also discuss the most recent meta-analysis that looked at all of the studies (except SPRINT) that have evaluated intensive blood pressure lowering. At the end we put the entire process into a perfect perspective that some have called earth shattering; and you can only find out what we think by becoming a PREMIUM member.
Show notes
1) The SPRINT trial
N Engl J Med 2015; 373:2103-16
2) Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis
November 6, 2015 http://dx.doi.org/10.1016/ S0140-6736(15)00805-3
Listening to this episode is for premium podcast members only. If you already have a membership, login to your account. If you aren't yet a premium subscriber, sign up today!
